OncoMyx Therapeutics

Founders: Steve Potts, Grant McFadden, Michael Wood,

Country: USA | Funding: $75M (+)

OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.